| Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities (NCT07144852) | Sun Pharmaceutical Industries, Inc. | 2025-11-29 |
| Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp (NCT07144345) | Sun Pharmaceutical Industries, Inc. | 2025-11-19 |
| A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. (NCT07546214) | Sun Pharmaceutical Industries, Inc. | 2025-10-13 |
| Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata (NCT07133308) | Sun Pharmaceutical Industries, Inc. | 2025-08-05 |
| A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris (NCT07469228) | Sun Pharmaceutical Industries, Inc. | 2025-08-04 |
| A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris (NCT06733402) | Sun Pharmaceutical Industries, Inc. | 2024-06-20 |
| A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. (NCT06673641) | Sun Pharmaceutical Industries, Inc. | 2024-05-13 |
| A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis. (NCT06673654) | Sun Pharmaceutical Industries, Inc. | 2023-08-11 |
| A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris (NCT06063473) | Sun Pharmaceutical Industries, Inc. | 2023-02-22 |
| European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata (NCT05041803) | Sun Pharmaceutical Industries, Inc. | 2021-10-19 |
| A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis. (NCT05282771) | Sun Pharmaceutical Industries, Inc. | 2021-04-16 |
| A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis. (NCT04883593) | Sun Pharmaceutical Industries, Inc. | 2020-09-03 |
| A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris (NCT04883736) | Sun Pharmaceutical Industries, Inc. | 2020-08-31 |
| A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris (NCT04797793) | Sun Pharmaceutical Industries, Inc. | 2020-05-18 |
| A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris (NCT04724473) | Sun Pharmaceutical Industries, Inc. | 2019-12-10 |
| Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata (NCT03898479) | Sun Pharmaceutical Industries, Inc. | 2019-04-04 |
| Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris (NCT04134273) | Sun Pharmaceutical Industries, Inc. | 2019-03-20 |
| To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis (NCT03880357) | Sun Pharmaceutical Industries, Inc. | 2018-10-22 |
| An Open-Label Study to Assess Safety (NCT03645499) | Sun Pharmaceutical Industries, Inc. | 2018-04-04 |
| Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream (NCT04358770) | Sun Pharmaceutical Industries, Inc. | 2018-03-02 |
| A Study Comparing Oxymetazoline 1% Cream to RHOFADE (NCT05148689) | Sun Pharmaceutical Industries, Inc. | 2018-02-23 |
| To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea (NCT03689010) | Sun Pharmaceutical Industries, Inc. | 2017-12-12 |